Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept studyFederica Miglietta, Valentina Guarneri, Carlo Alberto Giorgi et al.|ESMO Open|2024Cited by 7
178P PD-L1 expression in ER-low versus triple-negative (TN) advanced breast cancer (aBC), and according to phenotypic evolution from primary to recurrent diseaseFederica Miglietta, Maria Vittoria Dieci, Lorenzo Nicolè et al.|Annals of Oncology|2024Cited by 0